ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
5594 Centers for Disease Control and Prevention Html en Sulfuryl fluoride - NIOSH Pocket Guide to Chemical Hazards null
MPEG0.378858
search0.263099
PDF0.261307
PPT0.446092
DOC0.368812
information0.262482
different file formats0.938484
page0.276773
CLICK HERE
5922 Centers for Disease Control and Prevention Html en o-Nitrotoluene - NIOSH Pocket Guide to Chemical Hazards null
MPEG0.378858
search0.263099
PDF0.261307
PPT0.446092
DOC0.368812
information0.262482
different file formats0.938484
page0.276773
CLICK HERE
6485 Centers for Disease Control and Prevention Html en Implementing the MOVE! weight-management program in the Veterans Health Administration, 2007-2010: a qualitative study One-third of US veterans receiving care at Veterans Health Administration (VHA) medical facilities are obese and, therefore, at higher risk for developing multiple chronic diseases.
resource availability0.691782
program0.888295
senior management support0.661835
physician champion0.740844
new program participants0.634858
organizational factors0.677993
service line chiefs0.664568
facility chief nurse0.65394
innovation champion0.714888
evidence-based weight-management program0.72913
interview participants0.884816
medical center program0.64103
holistic case study0.638986
case study design0.642816
Qualitative data analysis0.642498
senior managers0.679688
primary care physicians0.829389
case study0.707047
health care facilities0.679466
different VHA facilities0.641143
primary care service-line0.64296
program implementation0.72786
obesity screening rates0.810744
innovation champions0.64698
management support0.7172
innovation implementation fosters0.672981
service-line chief support0.639389
case study research0.665436
multidisciplinary weight-management program0.681552
VHA medical facility0.663766
health care0.698156
VHA primary care0.650866
innovation0.8316
organizational readiness0.662825
program activity0.654868
weight-management program0.768434
multidisciplinary team0.689375
implementation0.941356
VHA policy0.698987
physical activity0.644247
national program officials0.67334
innovation implementation0.698704
treatment options0.680348
VHA facilities0.729625
primary care0.995444
Veterans Health Administration0.696845
VHA medical facilities0.838252
facilities0.934053
facility0.886055
CLICK HERE
6597 Centers for Disease Control and Prevention Html en Surveillance for Chronic Hepatitis B Virus Infection - New York City, June 2008-November 2009 Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.
chronic HBV patients0.639618
newly reported patients0.329966
chronic HBV population0.44802
hepatitis B virus0.300361
acute HBV0.432159
enhanced HBV surveillance0.455102
New York City0.400913
high HBV prevalence0.442568
HBV testing0.58734
HBV infection surveillance0.472579
vaccination status0.42683
newly-reported HBV patients0.478499
commonly reported reason0.357176
NYC clinicians0.313465
clinicians0.586804
HBV transmission0.408376
birth country0.466348
hepatitis A vaccination0.321206
HBV0.979922
enhanced surveillance0.299507
random sample0.305075
HBV surveillance0.58312
HBV surveillance database0.546195
risk factors0.344207
newly reported cases0.314309
limited hepatitis surveillance0.301041
HBV test results0.473828
DOHMH staff members0.328423
liver function test0.320672
chronic HBV infection0.818163
HBV infection status0.495096
confirmed chronic HBV0.467339
relevant clinicians0.305888
function test results0.321826
HBV prevalence0.506889
HBV core antigen.*0.47493
randomly selected HBV0.494646
HBV DNA0.45964
health departments0.306197
HBV patients0.652631
chronic HBV0.820352
staff members0.329461
elevated liver function0.320119
positive HBV test0.63336
HBV screening0.421713
chronic hepatitis0.324598
HBV infection0.904882
chronic HBV surveillance0.527085
close contacts0.306384
CLICK HERE
7508 Centers for Disease Control and Prevention Html en Disaster Training and Response - Preparedness and Response for Public Health Disasters The Health Studies Branch (HSB) provides expertise and leadership in epidemiology to local, state, federal and international partners to help them prepare for and respond to natural and man-made public health disasters. To do this, HSB conducts surveillance, rapid needs assessments, epidemiology studies, and provides training in disaster epidemiology to public health professionals.
HSB guidance document0.617214
public health disaster0.574451
public health practitioners0.351671
disaster response capacity0.492973
disaster epidemiology skills0.531188
disaster epidemiology0.951016
Health Studies Branch0.729349
Engaging At-Risk Groups0.31749
man-made disasters0.481058
Surveillance desk0.258744
HSB consultation0.539092
disaster preparedness0.36351
Environmental Health0.283374
disaster epidemiology training0.899604
public health partners0.522383
disaster-related rapid needs0.304299
public health emergencies0.544675
health emergency response0.402265
Emergency Operations Center0.329213
socially vulnerable populations0.300083
health surveillance data0.412546
international public health0.522448
Epidemiology Training Request0.374986
disaster preparation0.400359
final comprehensive capstone0.29058
shelter surveillance0.264538
morbidity surveillance0.279151
major public health0.414376
response training course0.348937
local health department0.354356
disaster response activities0.664015
at-risk groups0.416761
hsb disaster response0.986641
technical assistance0.442597
health services0.287236
Online Training Course0.31504
emergency response capacity0.353242
public health0.976279
emergency managers0.295214
response procedures0.258637
American Red Cross0.313624
mortality surveillance0.356238
rapid needs assessments0.458794
contact Health Studies0.3634
contact Amy Schnall0.299811
disaster experts0.393799
Download Participant Workbook0.289976
community needs assessment0.294482
Field Epidemiology0.266726
CLICK HERE
8835 Centers for Disease Control and Prevention Html en Notifiable Diseases and Mortality Tables - May 31, 2013 Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.
H. influenzae0.38509
National Center0.301929
cases0.377862
CDC0.294349
novel influenza0.641872
Total case counts0.45721
pandemic influenza0.948926
** Data0.348031
Cumulative total E.0.475364
measles case0.344225
Influenza Division0.440253
2009 pandemic0.76539
probable cases0.327103
Respiratory Diseases0.308257
rubella cases0.309464
human infection0.329695
influenza A virus0.474686
CLICK HERE
8903 Centers for Disease Control and Prevention Html en Malaria - About Malaria - FAQs Frequently asked questions about malaria, disease, transmission, symptoms, diagnosis, treatment, complications with pregnancy, prevention, eradication and endemic areas.
red blood cells0.390702
malaria medicines0.494516
professional medical care0.355949
contracting malaria0.493517
Page0.399529
effective antimalarial drugs0.366575
effective malaria vaccine0.505889
antimalarial drugs chloroquine0.358928
Plasmodium falciparum0.357673
malaria parasite0.553795
antimalarial drugs0.490421
P. falciparum0.339014
good antimalarial drugs0.359432
malaria infection0.504473
malaria drugs0.56295
flu-like illness0.354
area0.346392
Malaria self-treatment0.476341
countries0.346836
microscopic malaria parasites0.537481
Africa south0.345101
effective malaria treatment0.491815
malaria attacks0.473723
P. ovale0.378287
malaria parasites0.642919
malaria treatment medicines0.488916
antimalarial drug Malarone0.348517
malaria causes0.516926
United States0.508077
malaria exists0.477573
malaria0.906829
malaria preventive drugs0.502806
previous blood meal0.338326
P. vivax0.369454
No. Malaria0.503669
solid malaria control0.49259
transfusion-transmitted malaria0.479843
effective malaria0.514094
blood transfusion0.337891
principal malaria mosquito0.496796
malaria treatment medication0.489894
disease0.365987
breast milk0.35484
malaria immunity0.493244
people0.366376
infected person0.346204
health-care provider0.44702
malaria transmission0.769011
antimalarial drug0.397215
CLICK HERE
10925 Centers for Disease Control and Prevention Html en Effectiveness of Interventions to Increase Cancer Screening The Community Preventive Services Task Force published updated findings on the effectiveness of nine interventions aimed at increasing screening for breast, cervical, and colorectal cancers.
screening0.825295
evidence0.702476
Vernon SW0.484647
Health professionals0.491296
client incentives0.498477
lay people0.48984
one-on-one education0.643519
medical office0.490363
sufficient evidence0.586064
structural barriers0.519999
different settings0.490959
colorectal cancer screening0.79436
insufficient evidence0.585195
health advisor0.489435
Preventive Services Task0.750152
Wilson KM0.482698
Melvin CL0.488376
colorectal cancer0.856728
client reminders0.787952
cervical cancer screening0.749418
mass media0.495716
cervical cancers0.520315
telephone messages0.485305
American Journal0.484797
group education0.6356
Rimer BK0.495965
colorectal cancers0.650045
Preventive Medicine.0.505873
Mercer SL0.48551
group members0.494349
provider incentives0.494362
Sabatino SA0.489436
blood testing0.502669
public health care0.589479
strong evidence0.617647
teaching aids0.493319
suffıcient evidence0.631728
breast cancer0.51161
Services Task Force0.733804
community setting0.493461
one-on-one education increases0.611101
provider assessment0.493201
recipient’s characteristics0.489913
out-of-pocket costs0.497968
Community Preventive Services0.987048
telephone reminders0.521448
Community Guide0.506322
systematic reviews0.483978
FOBT screening0.71029
CLICK HERE
12476 Centers for Disease Control and Prevention Video en June 2013 ACIP Meeting -- Influenza Introduction by Dr. W Keitel. Epidemiology/surveillance update by Dr. L Finelli. H7N9 update by Dr. D Jernigan. Preliminary data on 2012-2013 vaccine effectiveness by Dr. M Thompson. Vaccine safety update by Dr. T Shimabukuro. FluLaval Quadrivalent: GSK's inactivated quadrivalent seasonal influenza vaccine manufactured in Quebec by Dr. V Jain. 2013-2013 recommendations by Dr. L Grohskopf. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at: http://streaming.cdc.gov/vod.php?id=346a288deb884b40d8e72dd413801af020130730150920062.
Influenza0.687666
ACIP Meeting0.965132
CLICK HERE
15963 Centers for Disease Control and Prevention Html en Zika Virus Infection and Microcephaly Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention.
Zika Virus Infection0.969937
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.